Tratamiento Obesidad Medicamentos para bajar de peso Lorcaserin HCl

Tratamiento Obesidad Medicamentos para bajar de peso Lorcaserin HCl

Detalle rápido

Product name Lorcaserin, Lorcaserin HCL
Synonyms Belviq ; (R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benz ; Clorhidrato de lorcaserina
CAS numbers: 616202-92-7
Fórmula molecular : C11H14ClN
Peso molecular : 195.6886
Ensayo : 99%
Punto de ebullición : 288.125°C at 760 mmHg
Flash point : 128.054° C
Apariencia : polvo blanco
Product usage : Medicine reducing weight and antidepressants

Product description

Lorcaserin HCl is a FDA-approved prescription weight loss drug that, when used in conjunction with diet and exercise, can help some weight-related medical problems overweight adults or obese adults lose weight and maintain physical condition. It is not known whether lovastatin HCl is safe and effective with other prescription, non-prescription or herbal weight loss products.

It is not known whether chlorotastatin HCl will change the risk of heart problems, stroke or death due to heart disease or stroke. Lomizine Hydrochloride is a serotonin 2C receptor agonist. By selectively activating the serotonin 2C receptor in the brain, it has been shown to reduce food consumption and promote SA anxiety. Carbacillin specifically expresses a cofactor for reducing calorie diets and increases physical activity (IMC de 30 kg / m2 or greater) y adultos con sobrepeso (IMC de 27 kg / m2) for chronic weight management in clinically obese patients ), Which has at least one weight-related comorbid condition. As a tablet designed for oral administration. The recommended dose is 10mg tablets twice daily. If the treatment did not reach 5% of the weight loss at week 12, HCl should be discontinued using chlorhexidine.

Lorcaserin HCl Applications:

belviq(clorhidrato de lorcaserina) is a serotonin 2C receptor agonist. It has been shown that by selectively activating the serotonin 2C receptor in the brain to reduce food consumption and promote satiety.

belviq(clorhidrato de lorcaserina) is specifically indicated as an adjunct to a reduced-calorie diet andincreased physical activity for chronic weight management in clinically obeseadults (IMC de 30 kg/m2 o más) y adultos con sobrepeso (IMC de 27 kg/m2 o mayor) con al menos una condición comórbida relacionada con el peso.